Literature DB >> 8320434

Thyroid disease and breast cancer.

P P Smyth1.   

Abstract

A review of the literature on the relationship between thyroid disorders and breast cancer does not provide conclusive evidence for the establishment of a causal relationship as breast cancer has been associated with hypothyroidism, hyperthyroidism and nontoxic goiter. Most reports on the association of thyroid enlargement and breast cancer have emanated from areas of endemic iodine deficiency and these reports have relied on neck palpation. The contribution of the present study is in the application of the highly sensitive technique of diagnostic ultrasound to the investigation of subtle changes in thyroid volume and anatomy in patients with breast cancer. The mean thyroid volume of 20.4 +/- 1.0 ml in 184 breast cancer patients was significantly greater than that of 12.9 +/- 1.2 ml in age-matched controls (p < 0.01). Also the number of individual patients with breast cancer having enlarged thyroid glands (73/184; 39.7%) was significantly greater than the corresponding number (13/150; 8.6%) in the control group (p < 0.001). There was a direct correlation between thyroid enlargement and breast tumour staging. Both mean thyroid volume and % of enlarged thyroids were identical in groups of patients scanned after (Retrospective Group) and before (Prospective Group) various therapies for breast cancer, thus excluding therapeutic intervention as a cause for thyroid enlargement. The results indicate a direct relationship between the two disorders perhaps involving a common growth stimulus and emphasise the importance of raising the consciousness of the coincidence of both disorders.

Entities:  

Mesh:

Year:  1993        PMID: 8320434     DOI: 10.1007/BF03348865

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  25 in total

1.  Cancer risk in population examined with diagnostic doses of 131I.

Authors:  L E Holm; K E Wiklund; G E Lundell; N A Bergman; G Bjelkengren; U B Ericsson; E S Cederquist; M E Lidberg; R S Lindberg; H V Wicklund
Journal:  J Natl Cancer Inst       Date:  1989-02-15       Impact factor: 13.506

2.  Iodine intake in Ireland--an update.

Authors:  P P Smyth; A M Hetherton; D O'Carroll; D F Smith; M J O'Halloran; D K O'Donovan
Journal:  Ir J Med Sci       Date:  1988-12       Impact factor: 1.568

3.  Thyroid status and breast cancer. Reappraisal of an old relationship.

Authors:  A R Moossa; D A Evans; A C Brewer
Journal:  Ann R Coll Surg Engl       Date:  1973-09       Impact factor: 1.891

4.  Relationship of thyroid disease and use of thyroid supplements to breast cancer risk.

Authors:  L A Brinton; D A Hoffman; R Hoover; J F Fraumeni
Journal:  J Chronic Dis       Date:  1984

5.  Thyroid disease and breast cancer: findings in a large case-control study.

Authors:  A Kalache; M P Vessey; K McPherson
Journal:  Br J Surg       Date:  1982-07       Impact factor: 6.939

6.  Neoplastic disease and thyrotoxicosis.

Authors:  H J Wanebo; R S Benua; R W Rawson
Journal:  Cancer       Date:  1966-11       Impact factor: 6.860

7.  Breast cancer in patients with Hashimoto's thyroiditis.

Authors:  K Ito; N Maruchi
Journal:  Lancet       Date:  1975-12-06       Impact factor: 79.321

8.  Breast cancer in thyroid disease: fact or fallacy?

Authors:  A J Hedley; S J Jones; D J Spiegelhalter; P Clements; P D Bewsher; J G Simpson; R D Weir
Journal:  Lancet       Date:  1981-01-17       Impact factor: 79.321

9.  Cancer incidence following treatment of hyperthyroidism.

Authors:  D A Hoffman; W M McConahey; J F Fraumeni; L T Kurland
Journal:  Int J Epidemiol       Date:  1982-09       Impact factor: 7.196

10.  High incidence of breast cancer in thyroid cancer patients.

Authors:  L J Chalstrey; B Benjamin
Journal:  Br J Cancer       Date:  1966-12       Impact factor: 7.640

View more
  6 in total

1.  High prevalence of breast cancer in patients with benign thyroid diseases.

Authors:  I Muller; A Pinchera; E Fiore; V Belardi; V Rosellini; E Giustarini; C Giani
Journal:  J Endocrinol Invest       Date:  2010-07-01       Impact factor: 4.256

2.  Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors.

Authors:  C J Guigon; D W Kim; M C Willingham; S-Y Cheng
Journal:  Oncogene       Date:  2011-03-14       Impact factor: 9.867

3.  Absence of interference of serum IgGs from patients with breast cancer and thyroid autoimmunity on the function of human iodide symporter gene stably transfected in CHO cells.

Authors:  P Fierabracci; A Pinchera; M Tonacchera; P Agretti; G De Marco; S Albertini; G Conforti; E Seregni; R Agresti; L Grasso; C Giani
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

4.  Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women.

Authors:  Ada Tosovic; Anne-Greth Bondeson; Lennart Bondeson; Ulla-Britt Ericsson; Johan Malm; Jonas Manjer
Journal:  Breast Cancer Res       Date:  2010-06-11       Impact factor: 6.466

5.  Wakame seaweed suppresses the proliferation of 7,12-dimethylbenz(a)-anthracene-induced mammary tumors in rats.

Authors:  H Funahashi; T Imai; Y Tanaka; K Tsukamura; Y Hayakawa; T Kikumori; T Mase; T Itoh; M Nishikawa; H Hayashi; A Shibata; Y Hibi; M Takahashi; T Narita
Journal:  Jpn J Cancer Res       Date:  1999-09

6.  The correlation between breast cancer and urinary iodine excretion levels.

Authors:  Fatma Umit Malya; Huseyin Kadioglu; Mustafa Hasbahceci; Kemal Dolay; Mehmet Guzel; Yeliz Emine Ersoy
Journal:  J Int Med Res       Date:  2017-08-31       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.